Select Page

Company to buy

  • Size: Small to medium business
  • Sales: 10 – 30 million EUR
  • Location: Europe
  • Reason for acquisition: The management wants to expand the business
  • #CFIE PHB198

Overview of buyer for radiation oncology company in Central Europe

A leading operator in nuclear medicine with a strong presence in Southern Europe and Asia seeks to expand its portfolio through strategic acquisitions. Currently, they are actively looking for companies in the field of oncology, radiology, radiotherapy, and PET/CT in Central Europe.

Profile (strategy) of buyer for radiation oncology company in Central Europe

Primarily, this leading healthcare partner has been focused on nuclear medicine and radiation oncology for more than 30 years. In general, the company provides operational solutions for these departments. At this time, it runs more than 50 nuclear medicine centers, 10 radiation oncology centers, and 3 oncology centers.
The company began its operations by taking over the operations of the International Hospital’s Nuclear Medicine Unit. Since then, they have expanded their service network significantly. Now, they provide services to hospitals and clinics throughout the country.

Overall, the company offers a wide range of services to its clients. More specifically, this includes procuring equipment, healthcare personnel, and radiopharmaceuticals. In addition, it manages nuclear medicine and radiation oncology departments while it ensures quality assurance and control. Equally important, are training and education, patient management, and research and development.

Significantly, the company is committed to providing high-quality services to its clients and patients. Further, they use the latest technology and techniques to ensure that their patients receive the best possible care. Above all, the company is also committed to providing relevant training and education to its staff. As a result, they can ensure that they are up-to-date on the latest developments in nuclear medicine and radiation oncology.

Subscribe as an interested seller
Contact us to get details about this buyer for radiation oncology in Center Europe

Activities and products of a suitable target

Essentially, the target company should have robust financial performance, with a favorable EBITDA margin. Preferably, the target should be in the field of oncology, radiology, radiotherapy, and PET/CT.

Highlights

A well-established nuclear medicine company with a strong presence in Southern Europe is seeking to expand its portfolio.

  • Leading provider of operational solutions for nuclear medicine and radiation oncology departments
  • Over 30 years of experience in the industry
  • Team of more than 180 experienced professionals with experience in the nuclear medicine and radiation oncology industry

More information on this buyer for radiation oncology company in Central Europe

Please get in touch if you are interested in learning more about this buyer for radiation oncology company in Central Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

en_GBEnglish (UK)